ENTITY
SK Bioscience

SK Bioscience (302440 KS)

176
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
bullishSK Bioscience
13 Apr 2021 13:44

SK Bioscience K200 Entry: Potential Trades Reflecting SK Biopharm's Passive Inflow Pattern

This post finds the similarities between SK Biopharm and SK Bioscience concerning the passive money inflow pattern for the KOSPI 200 fast entry.

Logo
240 Views
Share
06 Apr 2021 09:19

KOSPI 200 Rebalancing: SK BioS/SK IET Fast Entry & LG Corp New Entity (8 Added & 9 Deleted)

This post tracks the KOSPI 200 June review based on the average daily MC as of April 5. We have 8 additions, incl. SK BioS/SK IET fast entry as...

Logo
298 Views
Share
bullishSK Bioscience
06 Apr 2021 07:34

SK Bioscience IPO: KOSPI200 Fast Entry Guaranteed; SGBC Most Likely Deletion

SK Bioscience's Fast Entry into the KOSPI200 Index is almost guaranteed. We see SGBC as the most likely deletion. With a lot of shares still locked...

Logo
324 Views
Share
01 Apr 2021 20:28

SK IET IPO Preview

SK IET plans to complete its IPO in May.  The IPO price range is from 78,000 won to 105,000 won. The IPO base deal size is from $1.5 billion to...

Logo
579 Views
Share
bullishSK Bioscience
01 Apr 2021 10:47

SK Bioscience: K200 Fast Entry, Lock-Up Expiry, Loan/Short Balance, & Exit Points

This post checks the current situation of SK Bioscience on K200 fast entry, lock-up expiry, loan/short balance, and potential exit points.

Logo
485 Views
Share
x